MarketInOut Stock Screener Log In | Sign Up

Anthem Biosciences Ltd

BSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Anthem Biosciences Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization468,771 mln
Float107 mln
Earnings Date11/03/2026

EPS

10.35
Stretched

P / E

80.25
Speculative

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.42
Borderline

1-Year Forecast

920.12
Modest upside

Relative Strength

70 / 100
Outperforming

Business Description

Anthem Biosciences, founded in 2006 and headquartered in Bengaluru, India, helps pharmaceutical companies develop and manufacture complex medicines from early research through to commercial production. The company supports drug programs involving biologics, peptides, RNA therapies, and other advanced treatments, handling everything from initial discovery to large-scale manufacturing. It also produces and sells specialty ingredients, including fermentation-based pharmaceutical actives, probiotics, enzymes, and nutritional compounds.

Key Fundamentals

EPS10.35
P/E80.25
ROE21.06
RPS35.71
ROIC22.76
ROA18.15
Interest Cover106
EBITDA, mln9,264
EV / EBITDA52.41
EV / EBIT61.55
Revenue, mln20,023
EV / Revenue24.25

Quote Details

Last 830.55
Change 3.55 (0.43%)
Open 827.95
Volume 25,074
Turnover 20,825,210
Average Volume 245,982

Financial Ratios

Pre-Tax Profit Margin39
Current Ratio5.54
Price / Book15.80
Price / Tangible Book15.80
Price / Free Cash Flow68.80
Debt / Equity0.02
Price / Sales24.25

Financial Strength

Altman Z-Score78.9
Piotroski F-Score 7 / 9
Beneish M-Score-2.42
Price to Graham Number7.47
1-Year Target Price920.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.27% 64 / 100   
1 Month -4.67% 57 / 100   
2 Months 6.48% 78 / 100   
6 Months 7.35% 73 / 100   
1 Year 11.92% 80 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog